mimile
Back to feed

Nobel laureate David Baker leads AI BioDesign to create proteins not found in nature

1 min
Nobel laureate David Baker leads AI BioDesign to create proteins not found in nature

This digest was compiled by AI from multiple sources — links to the originals are below.

AI BioDesign, led by Nobel laureate David Baker, aims to design proteins and biological functions not found in nature using AI and large-scale lab experiments. The initiative is led by the Allen Institute, University of Washington, and Fred Hutchinson Cancer Center. The project seeks to create databases and tools for future medicines and technologies.

Key Facts

  • AI BioDesign is led by the Allen Institute, University of Washington, and Fred Hutchinson Cancer Center.
  • David Baker, who shared the 2024 Nobel Prize in Chemistry, is chief scientific officer at AI BioDesign.
  • The project aims to create databases, models, and tools that could serve as seeds for future medicines and technologies.
  • Researchers envision new drugs for cancer and neurodegenerative diseases, and enzymes to break down plastics in the ocean.

Project Leadership

AI BioDesign is led by the Allen Institute, a biomedical research nonprofit in Seattle, along with the University of Washington and the Fred Hutchinson Cancer Center. David Baker, who shared the 2024 Nobel Prize in Chemistry for computational protein design, serves as chief scientific officer. The project combines artificial intelligence and large-scale laboratory experiments to design and test new molecules and biological functions.

Scientific Approach

The natural world represents only a fraction of what might exist, and AI BioDesign explores possibilities that nature never produced. Researchers aim to create databases, models, and tools that could serve as seeds for developing future medicines and technologies. Envisioned applications include new drugs for cancer and neurodegenerative diseases, and enzymes capable of breaking down plastics in the ocean. Computational design allows evaluation of risks before a molecule is synthesized, including screening designs and contained laboratory testing.

1 source

Time · lag behind first